HIGH

Nivagen Zinc Oxide Ointment Recall 912 Containers Over cGMP Deviations (2025)

Nivagen Zinc Oxide Ointment 20% skin protectant, manufactured in India for Nivagen Pharmaceuticals and distributed nationwide in the USA, is recalled. The recall covers 912 containers. The defect cited is cGMP deviations. Consumers and healthcare providers should stop using the product and follow guidance from Blossom Pharmaceuticals or a healthcare professional.

Quick Facts at a Glance

Recall Date
October 31, 2025
Hazard Level
HIGH
Brand
Nivagen Zinc Oxide
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

cGMP deviations

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Blossom Pharmaceuticals or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Zinc oxide ointment is a topical skin protectant used to soothe and protect irritated skin. The 20% formulation is a high-concentration variant used in medical settings.

Why This Is Dangerous

cGMP deviations indicate manufacturing quality control issues that could affect product safety or potency. This may compromise product integrity until resolved.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Consumers and healthcare providers should treat this as a quality issue and use non-affected products until further guidance is issued.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the container: A352318.
  2. Verify the NDC on the packaging: 75834-170-15.
  3. Confirm net weight: 15 oz (425 g).
  4. Note the product is manufactured in India for Nivagen Pharmaceuticals, Inc.

Where to find product info

FDA enforcement report page for D-0206-2026. Recall notices may also be distributed by Blossom Pharmaceuticals.

What timeline to expect

Refunds or replacements, if available, typically follow 4-6 weeks after recall confirmation.

If the manufacturer is unresponsive

  • Document all contact attempts with Blossom Pharmaceuticals.
  • Escalate to the FDA recall contact if the company is unresponsive.
  • Consider filing a consumer complaint with CPSC if product misuse results in harm.

How to prevent similar issues

  • Verify product origin and lot numbers when purchasing zinc oxide ointments.
  • Buy from reputable retailers with clear recall policies.
  • Keep product packaging until recall is resolved.

Documentation advice

Keep the product packaging, store receipt if available, and all recall notices and correspondence with the company.

Product Details

Brand: Nivagen Zinc Oxide. Product: Zinc Oxide Ointment USP 20% Skin Protectant. Net weight: 15 oz (425 g). NDC: 75834-170-15. Lot: A352318. Manufactured in: India. Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA. Quantity recalled: 912 containers. Distribution: USA Nationwide. Sold from: Not disclosed. Recall date: 2025-10-31. Status: ACTIVE. Price: Unknown.

Key Facts

  • 912 containers recalled nationwide
  • NDC 75834-170-15
  • Lot A352318
  • Manufactured in India for Nivagen Pharmaceuticals, Inc.
  • Active recall status as of 2025-12-10

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
A352318
UPC Codes
75834-170
75834-170-01
75834-170-02
+1 more
Affected States
ALL
Report Date
December 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more